SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS
and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ARAUJO, Erika M.V WITTMAN, Mark D VELAPARTHI, Upender DARNE, Chetan Padmakar BORA, Rajesh Onkardas NAIR, Jalathi Surendran LIU, Peiying METTU, Mallikarjuna Rao PULICHARLA, Nagalakshmi PEARCE, Bradley C RACHAMREDDY, Chandrasekhar Reddy SISTLA, Ramesh Kumar BANDREDDY, Subba Reddy SELVAKUMAR, Kumaravel SUBBIAH KARUPPIAH, Arul Mozhi JANAKIRAMAN, Sakthi Kumaran HOLEHATTI, Shilpa Maheshwarappa MULLICK, Dibakar DASGUPTA, Bireshwar |
| description | and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3068785B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3068785B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3068785B13</originalsourceid><addsrcrecordid>eNqNissKgkAUQN20iOof7geMlJiP7ejc8FLMyMxVsAgRmVZRgv0_RfQBrc45cJbB6JrCMXHDqGAvEpGKLGRkK6tOWVN3Vp7NyVwikYTy-k3SCAottZKpRQfSQSkdkoYj6Y9ABGqLQLqigthYtw4Wt-E--82PqwAOyGUV-unZ-3kaRv_wrx7reJfmWZ4UUfzH8garnzPB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS</title><source>esp@cenet</source><creator>ARAUJO, Erika M.V ; WITTMAN, Mark D ; VELAPARTHI, Upender ; DARNE, Chetan Padmakar ; BORA, Rajesh Onkardas ; NAIR, Jalathi Surendran ; LIU, Peiying ; METTU, Mallikarjuna Rao ; PULICHARLA, Nagalakshmi ; PEARCE, Bradley C ; RACHAMREDDY, Chandrasekhar Reddy ; SISTLA, Ramesh Kumar ; BANDREDDY, Subba Reddy ; SELVAKUMAR, Kumaravel ; SUBBIAH KARUPPIAH, Arul Mozhi ; JANAKIRAMAN, Sakthi Kumaran ; HOLEHATTI, Shilpa Maheshwarappa ; MULLICK, Dibakar ; DASGUPTA, Bireshwar</creator><creatorcontrib>ARAUJO, Erika M.V ; WITTMAN, Mark D ; VELAPARTHI, Upender ; DARNE, Chetan Padmakar ; BORA, Rajesh Onkardas ; NAIR, Jalathi Surendran ; LIU, Peiying ; METTU, Mallikarjuna Rao ; PULICHARLA, Nagalakshmi ; PEARCE, Bradley C ; RACHAMREDDY, Chandrasekhar Reddy ; SISTLA, Ramesh Kumar ; BANDREDDY, Subba Reddy ; SELVAKUMAR, Kumaravel ; SUBBIAH KARUPPIAH, Arul Mozhi ; JANAKIRAMAN, Sakthi Kumaran ; HOLEHATTI, Shilpa Maheshwarappa ; MULLICK, Dibakar ; DASGUPTA, Bireshwar</creatorcontrib><description>and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190626&DB=EPODOC&CC=EP&NR=3068785B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190626&DB=EPODOC&CC=EP&NR=3068785B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ARAUJO, Erika M.V</creatorcontrib><creatorcontrib>WITTMAN, Mark D</creatorcontrib><creatorcontrib>VELAPARTHI, Upender</creatorcontrib><creatorcontrib>DARNE, Chetan Padmakar</creatorcontrib><creatorcontrib>BORA, Rajesh Onkardas</creatorcontrib><creatorcontrib>NAIR, Jalathi Surendran</creatorcontrib><creatorcontrib>LIU, Peiying</creatorcontrib><creatorcontrib>METTU, Mallikarjuna Rao</creatorcontrib><creatorcontrib>PULICHARLA, Nagalakshmi</creatorcontrib><creatorcontrib>PEARCE, Bradley C</creatorcontrib><creatorcontrib>RACHAMREDDY, Chandrasekhar Reddy</creatorcontrib><creatorcontrib>SISTLA, Ramesh Kumar</creatorcontrib><creatorcontrib>BANDREDDY, Subba Reddy</creatorcontrib><creatorcontrib>SELVAKUMAR, Kumaravel</creatorcontrib><creatorcontrib>SUBBIAH KARUPPIAH, Arul Mozhi</creatorcontrib><creatorcontrib>JANAKIRAMAN, Sakthi Kumaran</creatorcontrib><creatorcontrib>HOLEHATTI, Shilpa Maheshwarappa</creatorcontrib><creatorcontrib>MULLICK, Dibakar</creatorcontrib><creatorcontrib>DASGUPTA, Bireshwar</creatorcontrib><title>SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS</title><description>and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNissKgkAUQN20iOof7geMlJiP7ejc8FLMyMxVsAgRmVZRgv0_RfQBrc45cJbB6JrCMXHDqGAvEpGKLGRkK6tOWVN3Vp7NyVwikYTy-k3SCAottZKpRQfSQSkdkoYj6Y9ABGqLQLqigthYtw4Wt-E--82PqwAOyGUV-unZ-3kaRv_wrx7reJfmWZ4UUfzH8garnzPB</recordid><startdate>20190626</startdate><enddate>20190626</enddate><creator>ARAUJO, Erika M.V</creator><creator>WITTMAN, Mark D</creator><creator>VELAPARTHI, Upender</creator><creator>DARNE, Chetan Padmakar</creator><creator>BORA, Rajesh Onkardas</creator><creator>NAIR, Jalathi Surendran</creator><creator>LIU, Peiying</creator><creator>METTU, Mallikarjuna Rao</creator><creator>PULICHARLA, Nagalakshmi</creator><creator>PEARCE, Bradley C</creator><creator>RACHAMREDDY, Chandrasekhar Reddy</creator><creator>SISTLA, Ramesh Kumar</creator><creator>BANDREDDY, Subba Reddy</creator><creator>SELVAKUMAR, Kumaravel</creator><creator>SUBBIAH KARUPPIAH, Arul Mozhi</creator><creator>JANAKIRAMAN, Sakthi Kumaran</creator><creator>HOLEHATTI, Shilpa Maheshwarappa</creator><creator>MULLICK, Dibakar</creator><creator>DASGUPTA, Bireshwar</creator><scope>EVB</scope></search><sort><creationdate>20190626</creationdate><title>SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS</title><author>ARAUJO, Erika M.V ; WITTMAN, Mark D ; VELAPARTHI, Upender ; DARNE, Chetan Padmakar ; BORA, Rajesh Onkardas ; NAIR, Jalathi Surendran ; LIU, Peiying ; METTU, Mallikarjuna Rao ; PULICHARLA, Nagalakshmi ; PEARCE, Bradley C ; RACHAMREDDY, Chandrasekhar Reddy ; SISTLA, Ramesh Kumar ; BANDREDDY, Subba Reddy ; SELVAKUMAR, Kumaravel ; SUBBIAH KARUPPIAH, Arul Mozhi ; JANAKIRAMAN, Sakthi Kumaran ; HOLEHATTI, Shilpa Maheshwarappa ; MULLICK, Dibakar ; DASGUPTA, Bireshwar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3068785B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ARAUJO, Erika M.V</creatorcontrib><creatorcontrib>WITTMAN, Mark D</creatorcontrib><creatorcontrib>VELAPARTHI, Upender</creatorcontrib><creatorcontrib>DARNE, Chetan Padmakar</creatorcontrib><creatorcontrib>BORA, Rajesh Onkardas</creatorcontrib><creatorcontrib>NAIR, Jalathi Surendran</creatorcontrib><creatorcontrib>LIU, Peiying</creatorcontrib><creatorcontrib>METTU, Mallikarjuna Rao</creatorcontrib><creatorcontrib>PULICHARLA, Nagalakshmi</creatorcontrib><creatorcontrib>PEARCE, Bradley C</creatorcontrib><creatorcontrib>RACHAMREDDY, Chandrasekhar Reddy</creatorcontrib><creatorcontrib>SISTLA, Ramesh Kumar</creatorcontrib><creatorcontrib>BANDREDDY, Subba Reddy</creatorcontrib><creatorcontrib>SELVAKUMAR, Kumaravel</creatorcontrib><creatorcontrib>SUBBIAH KARUPPIAH, Arul Mozhi</creatorcontrib><creatorcontrib>JANAKIRAMAN, Sakthi Kumaran</creatorcontrib><creatorcontrib>HOLEHATTI, Shilpa Maheshwarappa</creatorcontrib><creatorcontrib>MULLICK, Dibakar</creatorcontrib><creatorcontrib>DASGUPTA, Bireshwar</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ARAUJO, Erika M.V</au><au>WITTMAN, Mark D</au><au>VELAPARTHI, Upender</au><au>DARNE, Chetan Padmakar</au><au>BORA, Rajesh Onkardas</au><au>NAIR, Jalathi Surendran</au><au>LIU, Peiying</au><au>METTU, Mallikarjuna Rao</au><au>PULICHARLA, Nagalakshmi</au><au>PEARCE, Bradley C</au><au>RACHAMREDDY, Chandrasekhar Reddy</au><au>SISTLA, Ramesh Kumar</au><au>BANDREDDY, Subba Reddy</au><au>SELVAKUMAR, Kumaravel</au><au>SUBBIAH KARUPPIAH, Arul Mozhi</au><au>JANAKIRAMAN, Sakthi Kumaran</au><au>HOLEHATTI, Shilpa Maheshwarappa</au><au>MULLICK, Dibakar</au><au>DASGUPTA, Bireshwar</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS</title><date>2019-06-26</date><risdate>2019</risdate><abstract>and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3068785B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A48%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ARAUJO,%20Erika%20M.V&rft.date=2019-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3068785B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |